Tejnaksh Healthcare Ltd.

Tejnaksh Healthcare Ltd.

BBSE:TEJNAKSH
11.78
INR
+0.43
(+3.79%)
0.59EPS
25.15P/E
306.74MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1.36
2.34
3.44
6.5
9.53
8.13
5.74
6.13
5.66
5.87
6.25
5.21
5.19
Basic EPS, GAAP
0.41
0.65
0.9
1.41
1.49
1.03
1.01
1.34
0.83
0.87
1.15
0.6
0.6
Free Cash Flow per Basic Share
0.04
1.47
-4.11
1.13
1.35
-0.07
0.3
0.02
0.58
1.57
-0.26
0.59
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.22
3.07
3.98
4.99
6.48
7.51
8.52
9.87
10.72
11.6
12.76
13.36
- -
Tangible Book Value per Share
1.22
3.07
2.26
2.77
4.05
4.97
6.42
7.73
8.52
9.35
11.06
11.7
- -
Basic Weighted Avg Shares
15
20
20
20
20
20
20
20
20
20
20
20
21
Sales/Revenue/Turnover
20
47
70
132
194
165
117
124
115
119
127
106
108
Operating Margin (%)
43.32
43.98
40.75
36.87
18.55
20.51
26.29
34.44
25.17
27.53
25.4
14.14
13.33
Depreciation Expense
1
2
3
5
6
7
7
6
9
9
9
14
14
Net Income, GAAP
6
13
18
29
30
21
21
27
17
18
23
12
12
Effective Tax Rate (%)
31.52
37.65
32.84
25.64
28.12
27.65
22.44
25.25
28.7
25.73
30.11
28.25
31.02
Profit Margin (%)
29.8
27.84
26.07
21.71
15.63
12.65
17.52
21.88
14.64
14.88
18.33
11.61
11.56
Working Capital
2
5
8
1
23
48
15
32
46
44
47
47
- -
LT Debt
4
- -
60
60
58
66
42
63
59
41
6
1
- -
Total Equity
25
62
82
104
135
157
178
206
224
242
265
276
- -
Return on Invested Capital (%)
- -
28.86
18.36
22.21
13.53
11.39
10.27
12.08
7.12
7.03
7.93
3.65
- -
Return on Capital (%)
- -
28.86
18.75
19.49
17.88
12.09
10.6
11.69
7.11
7.83
9.52
4.85
- -
Return on Common Equity (%)
- -
30.28
25.43
31.47
25.97
14.71
12.61
14.58
8.05
7.84
9.41
4.63
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
1
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
305
242
307

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
53
- -
Cash, Cash Equivalents & STI
- -
20
- -
Accounts Receivable, Net
- -
22
- -
Inventories
- -
8
- -
Total Current Liabilities
- -
6
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.4%
9.31%
4.5%
Free Cash Flow
133.93%
490.2%
-326.92%
Net Income, GAAP
5.19%
-3.23%
-47.24%
Sales/Revenue/Turnover
13.12%
-1.57%
-16.7%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
31
34
32
32
127
2026
26
30
26
26
106
2027
27
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.29
0.31
0.3
0.21
1.15
2026
0.12
0.15
0.15
0.17
0.6
2027
0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Ashish Vishwas Rawandale
Full Time Employees
34
Sector
Health services
Industry
Hospital/Nursing management
Address
Institute of Urology Mumbai MH India 424001
IPO Date
Sep 18, 2015
Business
Tejnaksh Healthcare Limited operates within the healthcare services sector, offering a broad spectrum of hospital and medical facilities. The company delivers specialized care across disciplines such as urology, nephrology, and dentistry, through its network of multi-specialty and super-specialty hospitals and clinics located across Maharashtra and other regions of India. Beyond patient care, it engages in research and development, manufactures and distributes healthcare equipment, and provides super-specialty training institutes. Established in 2003, Tejnaksh Healthcare is recognized for its commitment to clinical excellence, diagnostic innovation, and ethical standards in healthcare.